RECRUITING

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.

Official Title

Study to Evaluate the Usability of Introducing Integrated Digital Solutions Into Clinical Practice and the Value of Their Use in the Medical Care of Patients With Multiple Sclerosis (MS)

Quick Facts

Study Start:2024-10-21
Study Completion:2026-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05949580

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Able to comply with the study protocol, including having a smartphone and being able and willing to access the icompanion ms patient app on a regular basis. To use all functionalities of the icompanion ms patient app, the user's smartphone must comply with the minimum system requirements (Android version 5.0 or above, iOS version 11 or above)
  2. * Have a valid email address (for registration of icompanion ms)
  3. * Have a definite diagnosis of RRMS
  4. * Time since MS diagnosis ≥1 year
  5. * Medical history recorded for at least 1 year before enrollment
  6. * Expanded Disability Status Scale (EDSS) \<5.5
  1. * Any contra-indications to using icompanion ms patient app or website, as per the investigator's discretion
  2. * Inability to complete an MRI
  3. * Currently involved in an interventional trial
  4. * Diagnosis of progressive MS (primary progressive multiple sclerosis \[PPMS\] or secondary progressive multiple sclerosis \[SPMS\])

Contacts and Locations

Study Contact

MN44358 https://forpatients.roche.com/
CONTACT
888-662-6728 (U.S. Only)
global-roche-genentech-trials@gene.com

Principal Investigator

Clinical Trials
STUDY_DIRECTOR
icometrix

Study Locations (Sites)

Minneapolis Clinic of Neurology
Golden Valley, Minnesota, 55422
United States

Collaborators and Investigators

Sponsor: Hoffmann-La Roche

  • Clinical Trials, STUDY_DIRECTOR, icometrix

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-21
Study Completion Date2026-04-30

Study Record Updates

Study Start Date2024-10-21
Study Completion Date2026-04-30

Terms related to this study

Keywords Provided by Researchers

  • icobrain
  • icompanion
  • Multiple Sclerosis
  • Medical device
  • Patient app
  • Digital
  • Care management
  • Magnetic resonance imaging (MRI)
  • Deep learning
  • Artificial Intelligence (AI)
  • Patient Reported Outcomes (PRO)

Additional Relevant MeSH Terms

  • Relapsing Remitting Multiple Sclerosis